Ruffer LLP’s Biogen BIIB Stock Holding History

Ruffer LLP’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,500	Closed	-$815K	–	82
2019 Q3	$815K	Hold	3,500	–	–	0.02%	65
2019 Q2	$819K	Hold	3,500	–	–	0.02%	72
2019 Q1	$827K	Buy	+3,500	New	+$1.1M	0.02%	60

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Ruffer LLP's BIIB Position: Q4 2019 in Review

Ruffer LLP sold out of Biogen (BIIB) in Q4 2019, closing a stake of 3,500 shares — an estimated $815K sold.

Ruffer LLP first reported a position in BIIB in Q1 2019 and held it in 3 quarters. The position peaked at $827K in Q1 2019. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

Ruffer LLP reported no remaining Biogen position as of Q4 2019 after selling out during the quarter.
Ruffer LLP sold 3,500 Biogen shares in Q4 2019, an estimated $815K.
Ruffer LLP first reported a position in Biogen in Q1 2019 and held it in 3 quarters.
Ruffer LLP's Biogen position peaked at $827K in Q1 2019.
1,103 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on Ruffer LLP's 13F filing for Q4 2019, filed 6 Feb 2020.